Regulatory PathRegulatory requirements compared

Active substance

Thallous chloride tl 201

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
THALLOUS CHLORIDE TL 2011mCi/MLinjectable · injectionCURIUMPrescription23 Oct 1979
THALLOUS CHLORIDE TL 2011mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**injectable · injectionLANTHEUS MEDCLDiscontinued16 Dec 1977
THALLOUS CHLORIDE TL 2012mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**injectable · intravenousLANTHEUS MEDCLDiscontinued16 Dec 1977
THALLOUS CHLORIDE TL 2011mCi/MLinjectable · injectionGE HEALTHCAREDiscontinued1 Feb 1982
THALLOUS CHLORIDE TL 2011mCi/MLinjectable · injectionBRACCODiscontinued30 Dec 1982
THALLOUS CHLORIDE TL 2011mCi/MLinjectable · injectionTRACE LIFEDiscontinued21 Nov 2001
THALLOUS CHLORIDE TL 2012mCi/MLinjectable · intravenousCURIUMDiscontinued9 Nov 2006

Safety signals and safety-related labeling changes

All safety entries for thallous chloride tl 201 →

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.